Report Detail
Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3233996 |
- 02 April, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.
In 2018, the global Metabolic Disorder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Metabolic Disorder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Disorder Therapeutics development in United States, Europe and China.
The key players covered in this study
Novo Nordisk A/S
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck KgaA
Amgen, Inc.
AstraZeneca PLC
Actelion Pharmaceuticals Ltd.
Shire PLC
AbbVie, Inc.
Biocon Ltd.
BioMarin Pharmaceutical, Inc.
Bristol-Myers Squibb Company
Cipla, Inc.
CymaBay Therapeutics, Inc.
Market segment by Type, the product can be split into
Lysosomal Storage Diseases
Diabetes
Obesity
Inherited Metabolic Disorders
Hypercholesterolemia
Market segment by Application, split into
Oral
Parenteral
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Metabolic Disorder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Metabolic Disorder Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Metabolic Disorder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Metabolic Disorder Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Lysosomal Storage Diseases
- 1.4.3 Diabetes
- 1.4.4 Obesity
- 1.4.5 Inherited Metabolic Disorders
- 1.4.6 Hypercholesterolemia
- 1.5 Market by Application
- 1.5.1 Global Metabolic Disorder Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Oral
- 1.5.3 Parenteral
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Metabolic Disorder Therapeutics Market Size
- 2.2 Metabolic Disorder Therapeutics Growth Trends by Regions
- 2.2.1 Metabolic Disorder Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Metabolic Disorder Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Metabolic Disorder Therapeutics Market Size by Manufacturers
- 3.1.1 Global Metabolic Disorder Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Metabolic Disorder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Metabolic Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Metabolic Disorder Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Metabolic Disorder Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Metabolic Disorder Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Metabolic Disorder Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Metabolic Disorder Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Metabolic Disorder Therapeutics Market Size (2014-2019)
- 5.2 Metabolic Disorder Therapeutics Key Players in United States
- 5.3 United States Metabolic Disorder Therapeutics Market Size by Type
- 5.4 United States Metabolic Disorder Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Metabolic Disorder Therapeutics Market Size (2014-2019)
- 6.2 Metabolic Disorder Therapeutics Key Players in Europe
- 6.3 Europe Metabolic Disorder Therapeutics Market Size by Type
- 6.4 Europe Metabolic Disorder Therapeutics Market Size by Application
7 China
- 7.1 China Metabolic Disorder Therapeutics Market Size (2014-2019)
- 7.2 Metabolic Disorder Therapeutics Key Players in China
- 7.3 China Metabolic Disorder Therapeutics Market Size by Type
- 7.4 China Metabolic Disorder Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Metabolic Disorder Therapeutics Market Size (2014-2019)
- 8.2 Metabolic Disorder Therapeutics Key Players in Japan
- 8.3 Japan Metabolic Disorder Therapeutics Market Size by Type
- 8.4 Japan Metabolic Disorder Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Metabolic Disorder Therapeutics Market Size (2014-2019)
- 9.2 Metabolic Disorder Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Metabolic Disorder Therapeutics Market Size by Type
- 9.4 Southeast Asia Metabolic Disorder Therapeutics Market Size by Application
10 India
- 10.1 India Metabolic Disorder Therapeutics Market Size (2014-2019)
- 10.2 Metabolic Disorder Therapeutics Key Players in India
- 10.3 India Metabolic Disorder Therapeutics Market Size by Type
- 10.4 India Metabolic Disorder Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Metabolic Disorder Therapeutics Market Size (2014-2019)
- 11.2 Metabolic Disorder Therapeutics Key Players in Central & South America
- 11.3 Central & South America Metabolic Disorder Therapeutics Market Size by Type
- 11.4 Central & South America Metabolic Disorder Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Novo Nordisk A/S
- 12.1.1 Novo Nordisk A/S Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Metabolic Disorder Therapeutics Introduction
- 12.1.4 Novo Nordisk A/S Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.1.5 Novo Nordisk A/S Recent Development
- 12.2 Sanofi S.A.
- 12.2.1 Sanofi S.A. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Metabolic Disorder Therapeutics Introduction
- 12.2.4 Sanofi S.A. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.2.5 Sanofi S.A. Recent Development
- 12.3 Boehringer Ingelheim GmbH
- 12.3.1 Boehringer Ingelheim GmbH Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Metabolic Disorder Therapeutics Introduction
- 12.3.4 Boehringer Ingelheim GmbH Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.3.5 Boehringer Ingelheim GmbH Recent Development
- 12.4 Eli Lilly and Company
- 12.4.1 Eli Lilly and Company Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Metabolic Disorder Therapeutics Introduction
- 12.4.4 Eli Lilly and Company Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.4.5 Eli Lilly and Company Recent Development
- 12.5 Merck KgaA
- 12.5.1 Merck KgaA Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Metabolic Disorder Therapeutics Introduction
- 12.5.4 Merck KgaA Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.5.5 Merck KgaA Recent Development
- 12.6 Amgen, Inc.
- 12.6.1 Amgen, Inc. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Metabolic Disorder Therapeutics Introduction
- 12.6.4 Amgen, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.6.5 Amgen, Inc. Recent Development
- 12.7 AstraZeneca PLC
- 12.7.1 AstraZeneca PLC Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Metabolic Disorder Therapeutics Introduction
- 12.7.4 AstraZeneca PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.7.5 AstraZeneca PLC Recent Development
- 12.8 Actelion Pharmaceuticals Ltd.
- 12.8.1 Actelion Pharmaceuticals Ltd. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Metabolic Disorder Therapeutics Introduction
- 12.8.4 Actelion Pharmaceuticals Ltd. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.8.5 Actelion Pharmaceuticals Ltd. Recent Development
- 12.9 Shire PLC
- 12.9.1 Shire PLC Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Metabolic Disorder Therapeutics Introduction
- 12.9.4 Shire PLC Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.9.5 Shire PLC Recent Development
- 12.10 AbbVie, Inc.
- 12.10.1 AbbVie, Inc. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Metabolic Disorder Therapeutics Introduction
- 12.10.4 AbbVie, Inc. Revenue in Metabolic Disorder Therapeutics Business (2014-2019)
- 12.10.5 AbbVie, Inc. Recent Development
- 12.11 Biocon Ltd.
- 12.12 BioMarin Pharmaceutical, Inc.
- 12.13 Bristol-Myers Squibb Company
- 12.14 Cipla, Inc.
- 12.15 CymaBay Therapeutics, Inc.
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Metabolic Disorder Therapeutics. Industry analysis & Market Report on Metabolic Disorder Therapeutics is a syndicated market report, published as Global Metabolic Disorder Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Metabolic Disorder Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
